AU3619795A - Substituted heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors - Google Patents

Substituted heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors

Info

Publication number
AU3619795A
AU3619795A AU36197/95A AU3619795A AU3619795A AU 3619795 A AU3619795 A AU 3619795A AU 36197/95 A AU36197/95 A AU 36197/95A AU 3619795 A AU3619795 A AU 3619795A AU 3619795 A AU3619795 A AU 3619795A
Authority
AU
Australia
Prior art keywords
alkyl amines
cyclase inhibitors
substituted heterobicyclic
oxide cyclase
squalene oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36197/95A
Other languages
English (en)
Inventor
Kazumasa Hamamura
Yasuo Sugiyama
Muneo Takatani
Ryuichi Tozawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU3619795A publication Critical patent/AU3619795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU36197/95A 1994-10-11 1995-10-09 Substituted heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors Abandoned AU3619795A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP24570494 1994-10-11
JP7-210893 1995-08-18
JP21089395 1995-08-18
JP6-245704 1995-08-18
PCT/JP1995/002062 WO1996011201A1 (en) 1994-10-11 1995-10-09 Substituted heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors

Publications (1)

Publication Number Publication Date
AU3619795A true AU3619795A (en) 1996-05-02

Family

ID=26518319

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36197/95A Abandoned AU3619795A (en) 1994-10-11 1995-10-09 Substituted heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors

Country Status (7)

Country Link
US (1) US5998433A (https=)
EP (1) EP0785939A1 (https=)
CN (1) CN1160403A (https=)
AU (1) AU3619795A (https=)
CA (1) CA2200469A1 (https=)
TW (1) TW320632B (https=)
WO (1) WO1996011201A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751644A1 (fr) * 1996-07-26 1998-01-30 Hoechst Schering Agrevo Sa Nouveaux amides aromatiques, leur procede de fabrication et leur application comme pesticides
CN1228087A (zh) * 1996-08-14 1999-09-08 曾尼卡有限公司 取代的嘧啶衍生物和它们的药物用途
US6339096B1 (en) * 1998-01-29 2002-01-15 Boehringer Ingelheim Pharma Kg Urethanes derived from azacycloalkanes, the thio and dithio analogues thereof and their use as cholesterol biosynthesis inhibitors
US6267461B1 (en) 1998-06-23 2001-07-31 James L. Dunagan Sport ball storage apparatus and method for storing and dispensing a sport ball
ATE328887T1 (de) * 1999-01-19 2006-06-15 Neurosearch As Kondensierte heterocyclische verbindungen und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
US20040010818A1 (en) * 2002-05-09 2004-01-15 Mcgonigle Brian Transgenic plants with a suppressed triterpene level
ES2398694T3 (es) * 2004-06-30 2013-03-21 Athersys, Inc. Derivados de azepina sustituidos como moduladores de receptores de serotonina
WO2007050124A1 (en) * 2005-05-19 2007-05-03 Xenon Pharmaceuticals Inc. Fused piperidine derivatives and their uses as therapeutic agents
KR101503681B1 (ko) 2006-01-19 2015-03-19 아더시스 인코포레이티드 세로토닌 5-ｈｔ2ｃ 수용체 리간드로서의 티오페닐 및 피롤릴 아제핀 및 이의 용도
US10143686B2 (en) 2010-12-27 2018-12-04 The Curators Of The University Of Missouri Oxidosqualene cyclase as a protein target for anticancer therapeutics
US9284277B2 (en) 2012-12-21 2016-03-15 Abt Holding Company Benzazepines as serotonin 5-HT2C receptor ligands and uses thereof
US9309262B2 (en) 2013-03-13 2016-04-12 Abt Holding Company Thienylindole azepines as serotonin 5-HT2C receptor ligands and uses thereof
US10040804B2 (en) 2016-12-21 2018-08-07 Biotheryx, Inc. Compounds targeting proteins, compositions, methods, and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2395028A2 (fr) * 1977-06-22 1979-01-19 Centre Etd Ind Pharma Derives pyridiniques, leur preparation et leurs application therapeutique
IL71661A0 (en) * 1983-04-27 1984-07-31 Boehringer Ingelheim Kg 4-phenyl-tetrahydro-furano-pyridines,their preparation and pharmaceutical compositions containing them
FR2652579B1 (fr) * 1989-10-02 1992-01-24 Sanofi Sa Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique.
US5143919A (en) * 1990-08-17 1992-09-01 Takeda Chemical Industries, Ltd. Thienopyridine derivatives and their pharmaceutical use
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
WO1993013105A1 (en) * 1991-12-26 1993-07-08 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists

Also Published As

Publication number Publication date
WO1996011201A1 (en) 1996-04-18
US5998433A (en) 1999-12-07
EP0785939A1 (en) 1997-07-30
CA2200469A1 (en) 1996-04-18
TW320632B (https=) 1997-11-21
CN1160403A (zh) 1997-09-24

Similar Documents

Publication Publication Date Title
PL348042A1 (en) Benzamide derivatives and their use as apob-100 secretion inhibitors
PL350900A1 (en) Heterocyclic containing biphenyl ap2 inhibitors and method
EP0813533A4 (en) N-CYCLOALKYLMETHYL-1H-PYRAZOLO 3,4-b] SUBSTITUTED QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF
IL144214A0 (en) Benzoheterocycles and their use as mek inhibitors
PL333918A1 (en) Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors
HU9601475D0 (en) Substituted n-(indolo-2-carbonyl)-glycinamides and derivatives as antidiabetic agents
HUP9903974A3 (en) Substituted pyridine derivatives as selective cyclooxigenase-2 inhibitors and use thereof
HUP0101804A3 (en) Adjuvant composition and methods for its use
HUP0101809A3 (en) Inhibitors of type 5 and type 3 17betha-hydroxysteroid dehydrogenase and methods for their use
PL314603A1 (en) Substituted n-(indolo-2-carbonyl)-beta-alaninamides and their derivatives as antidiabetic agents
SG50636A1 (en) Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
EP0828485A4 (en) USE OF THE R-ENANTIOMER OF N-PROPARGYL-1-AMINOINDANE, ITS SALTS AND COMPOSITIONS
IL152078A0 (en) 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
IL138906A0 (en) Quinolones used as mrs inhibitors and bactericides
PL330482A1 (en) Novel amino acid derivatives and their application as thrombosin inhibitors
PL335378A1 (en) Derivatives of inverse hydroxamates as metaloprotease inhibitors
AU3619795A (en) Substituted heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors
WO2001041823A8 (en) Radioactive compositions and methods of use thereof
AU2735995A (en) Hydroxylamine derivatives and their use as metalloproteinase inhibiting agents
HUP9900071A3 (en) Tribenzimidazoles useful as topoisomerase i inhibitors, pharmaceutical compositions containing them and their use
PL334304A1 (en) Derivatives of aromatic amines acting as nos inhibitors
AU4501199A (en) 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
AU1766997A (en) Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors
AU4415797A (en) New pde iv inhibitors: "bis-compounds"
AU1243392A (en) Prostacycline and carbacycline derivatives as agents for treating feverish complaints